Your browser doesn't support javascript.
loading
Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection.
Merani, Rohan; Johnson, Mark W; McCannel, Colin A; Flynn, Harry W; Scott, Ingrid U; Hunyor, Alex P.
Afiliação
  • Merani R; Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Johnson MW; Save Sight Institute, Specialty of Clinical Ophthalmology and Eye Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • McCannel CA; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW Australia.
  • Flynn HW; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
  • Scott IU; UCLA Stein Eye Institute; Department of Ophthalmology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
  • Hunyor AP; Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL, USA.
J Vitreoretin Dis ; 6(6): 443-451, 2022.
Article em En | MEDLINE | ID: mdl-37009541
ABSTRACT
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article